Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

BSX

Boston Scientific Corp

Feb 13 • 04:00PM ET

74.73

+0.61 0.82 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO VUG IVV SPY XLV VHT IHI MGK SPYM

Index	S&P 500	P/E	38.54	EPS (ttm)	1.94	Insider Own	0.38%	Shs Outstand	1.48B	Perf Week	-2.02%
Market Cap	110.83B	Forward P/E	19.05	EPS next Y	3.92	Insider Trans	-5.91%	Shs Float	1.48B	Perf Month	-20.28%
Enterprise Value	121.73B	PEG	1.43	EPS next Q	0.79	Inst Own	93.73%	Short Float	1.91%	Perf Quarter	-28.23%
Income	2.90B	P/S	5.52	EPS this Y	13.18%	Inst Trans	0.69%	Short Ratio	2.12	Perf Half Y	-28.25%
Sales	20.07B	P/B	4.74	EPS next Y	13.30%	ROA	6.91%	Short Interest	28.28M	Perf YTD	-21.63%
Book/sh	15.78	P/C	80.72	EPS next 5Y	13.30%	ROE	12.66%	52W High	109.50 -31.75%	Perf Year	-29.59%
Cash/sh	0.93	P/FCF	28.98	EPS past 3/5Y	63.25% -	ROIC	8.29%	52W Low	72.69 2.81%	Perf 3Y	56.70%
Dividend Est.	-	EV/EBITDA	25.37	Sales past 3/5Y	16.54% 15.16%	Gross Margin	70.32%	Volatility	2.47% 3.12%	Perf 5Y	94.66%
Dividend TTM	-	EV/Sales	6.06	EPS Y/Y TTM	55.39%	Oper. Margin	19.43%	ATR (14)	2.93	Perf 10Y	349.10%
Dividend Ex-Date	-	Quick Ratio	0.96	Sales Y/Y TTM	19.88%	Profit Margin	14.44%	RSI (14)	26.04	Recom	1.23
Dividend Gr. 3/5Y	- -	Current Ratio	1.51	EPS Q/Q	18.30%	SMA20	-12.35%	Beta	0.71	Target Price	105.27
Payout	0.00%	Debt/Eq	0.51	Sales Q/Q	15.90%	SMA50	-18.09%	Rel Volume	1.01	Prev Close	74.12
Employees	53000	LT Debt/Eq	0.49	Earnings	Feb 04 BMO	SMA200	-24.92%	Avg Volume	13.33M	Price	74.73
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.49% 0.12%	Trades		Volume	13,450,953	Change	0.82%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55

Show Previous Ratings

Feb-13-26 09:38AM	Will ISRG's R&D Focus Following Solid Earnings Growth Drive Demand? (Zacks)
08:00AM	Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference (PR Newswire)
07:57AM	BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
Feb-12-26 11:04AM	Renaissance Loads Up on Netflix, Lam Research, ServiceNow - Smart Money Signals Shift (Benzinga)
Feb-11-26 12:41AM	The Top 5 Analyst Questions From Boston Scientific's Q4 Earnings Call (StockStory)
05:53AM	Loading…
Feb-10-26 05:53AM	4 takeaways from the 2026 AF Symposium (MedTech Dive)
Feb-09-26 02:36PM	Top Research Reports for Bank of America, Toyota Motor & Shell (Zacks)
10:40AM	GEHC Strengthens AI Fetal Ultrasound via Diagnoly Collaboration (Zacks)
Feb-08-26 08:39AM	Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? (Benzinga)
Feb-07-26 08:12AM	Truist Cuts Boston Scientific Corporation (BSX) Price Target but Maintains Buy After Earnings Pullback (Insider Monkey)
Feb-06-26 09:31AM	Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips (Zacks)
08:15AM	The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk (24/7 Wall St.)
08:08AM	Boston Scientific price target lowered to $110 from $125 at Stifel (TipRanks)
Feb-05-26 12:33PM	DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features (Zacks)
10:27AM	CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains (Zacks)
09:45AM	Loading…
09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
09:25AM	STE Q3 Earnings Meet, Revenues Beat, Stock Dips in Aftermarket Trading (Zacks)
09:00AM	Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results (TipRanks)
08:23AM	Boston Scientifics shares tumble 18% despite strong FY25 growth (Medical Device Network)
05:44AM	J.P. Morgan Healthcare Conference 2026 Report (Pharmaceutical Technology)
12:34AM	BSX Q4 Deep Dive: Growth Engines Face Scrutiny as Market Reacts to Guidance and Segment Dynamics (StockStory)
12:07AM	Boston Scientific Q4 Earnings Call Highlights (MarketBeat)
Feb-04-26 05:41PM	Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors (Motley Fool) -17.59%
04:41PM	These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More (Barrons.com)
04:09PM	Boston Scientific Hits An 18-Month Low On A 'Sore Spot' For Its Most Hyped Device (Investor's Business Daily)
02:03PM	Boston Scientific Corp (BSX) Q4 2025 Earnings Call Highlights: Surpassing Financial Goals with ... (GuruFocus.com)
01:56PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
01:21PM	Why Boston Scientific Stock Plummeted Today (Motley Fool)
01:20PM	Software Stocks Plummet, Bitcoin Erases Post-Trump Election Rally: What's Moving Markets Wednesday? (Benzinga)
01:16PM	Boston Scientific (BSX) Earnings Transcript (Motley Fool)
12:57PM	Loading…
12:57PM	Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test (Zacks)
12:47PM	Stock Market Today: Dow Rises, Nasdaq Sinks Amid Tech Sell-Off; This Medical Stock Tumbles (Live Coverage) (Investor's Business Daily)
12:25PM	Why Boston Scientific (BSX) Shares Are Getting Obliterated Today (StockStory)
12:15PM	BSX Stock Dips in Premarket Trading Despite Q4 Earnings, Revenue Beat (Zacks)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:55AM	Reasons to Hold Veeva Systems Stock in Your Portfolio for Now (Zacks)
11:03AM	GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls (Zacks)
10:42AM	Texas Instruments to buy Silicon Labs, Enphase stock surges 40% (Yahoo Finance Video)
10:32AM	AMD Earnings Beat Expectations. Why Its One of the S&P 500s Worst Stocks Today. (Barrons.com)
10:30AM	Boston Scientific Earnings Beat Estimates. Its the Worst Stock in the S&P 500 Today. (Barrons.com)
10:03AM	Boston Scientific Stock Hits 52-Week Low On Soft 2026 Outlook (Benzinga)
09:34AM	TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up (Zacks)
09:30AM	Boston Scientific (BSX) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
09:19AM	Boston Scientific Profit, Sales Rise but Issues Soft Guidance (The Wall Street Journal)
08:12AM	Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. (Barrons.com)
08:02AM	Boston Scientific shares slide on cautious 2026 revenue forecast (Reuters)
07:40AM	Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:41AM	Boston Scientific: Q4 Earnings Snapshot (Associated Press Finance)
06:40AM	Boston Scientific (NYSE:BSX) Reports Q4 CY2025 In Line With Expectations (StockStory)
06:30AM	Boston Scientific announces results for fourth quarter and full year 2025 (PR Newswire)
05:24AM	Uber and Alphabet headline earnings slate (MarketWatch)
04:36AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
04:24AM	Stock Market Today: Dow, S&P 500 and Nasdaq consolidate after software rout; AMD results weigh; Alphabet earnings on tap; gold recovers $5,000 level. (MarketWatch)
Feb-03-26 01:13PM	GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut (Zacks)
12:02PM	Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions (Zacks)
11:18AM	Silver Economy Boom: Investing in Healthcare's Aging Tailwinds (Zacks)
10:29AM	Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test (Zacks)
10:23AM	DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand (Zacks)
08:29AM	MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More (Zacks)
05:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Revised) (Zacks)
03:01AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-02-26 10:03PM	Earnings To Watch: Boston Scientific (BSX) Reports Q4 Results Tomorrow (StockStory)
06:02PM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
09:51AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
09:49AM	Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates (Zacks)
09:08AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
02:13AM	Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-01-26 11:13PM	Deal fever returns: 2026 looks hot for M&A (TheStreet)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-30-26 04:57PM	Jobs Report, More Tech Earnings: What to Watch Next Week (The Wall Street Journal)
02:31PM	Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition (Insider Monkey)
01:34PM	GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test (Zacks)
12:07PM	SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval (Zacks)
10:25AM	SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption (Zacks)
09:15AM	Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Jan-29-26 01:32PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
01:28PM	Organon Completes Divesture of JADA System to Laborie Medical (Zacks)
12:47PM	Reasons to Add AngioDynamics Stock to Your Portfolio for Now (Zacks)
12:17PM	CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up (Zacks)
08:48AM	Thermo Fisher's Q4 Earnings & Revenues Top Estimates, Stock Climbs (Zacks)
08:32AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
01:38AM	Boston Scientific Stock: Analyst Estimates & Ratings (Barchart)
Jan-28-26 12:35PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
12:31PM	OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System (Zacks)
11:26AM	QT Imaging & Olea Medical Partner to Enhance Cloud Imaging Platform (Zacks)
09:04AM	Boston Scientific Corporation (BSX): A Bull Case Theory (Insider Monkey)
08:24AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
07:27AM	Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings? (Zacks)
Jan-27-26 12:07PM	ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures (Zacks)
11:47AM	BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry (Zacks)
07:53AM	CLPT Gets EU MDR Certification for ClearPoint Navigation Software (Zacks)
Jan-26-26 03:09PM	Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage (CNBC TV)
11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
07:24AM	Boston Scientific touts long-term data of SCS therapy (Medical Device Network)
05:39AM	Medtronic wins CE mark for single-shot pulsed field ablation catheter (MedTech Dive)
05:06AM	Intuitives cardiac initiative includes valve repair, LAA closure (MedTech Dive)
Jan-24-26 01:18AM	Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. (Barrons.com)
Jan-23-26 10:58PM	Oppenheimer Questions Valuation of Boston Scientific's $14.5 Billion Penumbra Deal (Insider Monkey)
06:00PM	Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mahoney Michael F	Chairman, President & CEO	Feb 02 '26	Option Exercise	25.78	95,754	2,468,482	1,572,636	Feb 03 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Feb 02 '26	Sale	93.49	160,901	15,043,394	1,411,735	Feb 03 04:12 PM
MICHAEL F MAHONEY	Officer	Feb 02 '26	Proposed Sale	93.49	160,901	15,043,390		Feb 02 04:12 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Option Exercise	24.81	17,313	429,491	40,913	Dec 02 05:04 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Sale	101.55	17,313	1,758,189	23,600	Dec 02 05:04 PM
ARTHUR C BUTCHER	Officer	Dec 01 '25	Proposed Sale	101.55	17,313	1,758,188		Dec 01 04:02 PM
Zane Ellen M	Director	Nov 06 '25	Sale	98.28	12,891	1,266,978	24,134	Nov 06 04:34 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Nov 04 04:15 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Sale	99.47	50,000	4,973,338	178,342	Nov 04 04:15 PM
JOSEPH M FITZGERALD	Officer	Nov 03 '25	Proposed Sale	99.47	50,000	4,973,335		Nov 03 04:05 PM
Zane Ellen M	Director	Oct 27 '25	Sale	101.13	9,990	1,010,301	27,035	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Sale	102.24	2,901	296,599	24,134	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Proposed Sale	102.24	2,901	296,592		Oct 28 10:55 AM
Zane Ellen M	Director	Oct 27 '25	Proposed Sale	100.91	9,990	1,008,081		Oct 27 10:50 AM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Oct 01 04:22 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Sale	98.47	50,000	4,923,327	178,342	Oct 01 04:22 PM
JOSEPH M FITZGERALD	Officer	Oct 01 '25	Proposed Sale	98.47	50,000	4,923,325		Oct 01 04:04 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM

Open in Screener

STAA

Staar Surgical Co

Feb 13 • 04:00PM ET

16.10

-0.39 -2.37 %

Healthcare • Medical Instruments & Supplies • USA • NASD

STAA Staar Surgical Co daily Stock Chart

Peers: JNJ ALGN ISRG MDT ABT NVS BSX EW EYE SYK

| Held by: IJR VTI IWM VB VXF VBK SPSM IWO VTWO SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.96	Insider Own	0.85%	Shs Outstand	49.35M	Perf Week	-8.42%
Market Cap	800.85M	Forward P/E	38.32	EPS next Y	0.42	Insider Trans	457.45%	Shs Float	49.32M	Perf Month	-26.21%
Enterprise Value	647.31M	PEG	0.94	EPS next Q	0.18	Inst Own	108.63%	Short Float	8.12%	Perf Quarter	-37.72%
Income	-96.37M	P/S	3.47	EPS this Y	-89.53%	Inst Trans	-10.32%	Short Ratio	2.90	Perf Half Y	-43.65%
Sales	230.59M	P/B	2.25	EPS next Y	1767.11%	ROA	-19.39%	Short Interest	4.01M	Perf YTD	-30.27%
Book/sh	7.17	P/C	4.16	EPS next 5Y	40.96%	ROE	-24.65%	52W High	30.81 -47.74%	Perf Year	0.88%
Cash/sh	3.87	P/FCF	-	EPS past 3/5Y	- -	ROIC	-24.86%	52W Low	14.69 9.60%	Perf 3Y	-76.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.85% 15.89%	Gross Margin	72.18%	Volatility	4.09% 4.56%	Perf 5Y	-87.02%
Dividend TTM	-	EV/Sales	2.81	EPS Y/Y TTM	-540.37%	Oper. Margin	-28.42%	ATR (14)	0.87	Perf 10Y	156.37%
Dividend Ex-Date	-	Quick Ratio	4.35	Sales Y/Y TTM	-32.42%	Profit Margin	-41.79%	RSI (14)	20.71	Recom	3.18
Dividend Gr. 3/5Y	- -	Current Ratio	5.21	EPS Q/Q	-12.41%	SMA20	-12.90%	Beta	1.09	Target Price	23.53
Payout	-	Debt/Eq	0.11	Sales Q/Q	6.93%	SMA50	-25.50%	Rel Volume	0.58	Prev Close	16.49
Employees	1211	LT Debt/Eq	0.10	Earnings	Nov 05 AMC	SMA200	-28.80%	Avg Volume	1.38M	Price	16.10
IPO	Jul 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.16% 0.03%	Trades		Volume	805,650	Change	-2.37%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-26	Initiated	Wedbush	Neutral	$26
Jan-16-26	Resumed	Morgan Stanley	Underweight	$13
Apr-21-25	Initiated	Wells Fargo	Equal Weight	$17
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral	$45 → $17
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy

Show Previous Ratings

Feb-09-26 11:37PM	1 Cash-Heavy Stock on Our Watchlist and 2 We Brush Off (StockStory)
Feb-05-26 10:00AM	West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy? (Zacks)
07:55AM	Cardinal Health (CAH) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Feb-04-26 01:27PM	STAAR Surgical Company (STAA): A Bull Case Theory (Insider Monkey)
Feb-03-26 10:00AM	Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
09:34AM	Loading…
09:34AM	Adobe downgraded, Palantir upgraded: Wall Street's top analyst calls (The Fly)
05:23AM	STAAR names interim co-CEOs amid search for permanent leader (MedTech Dive)
Feb-02-26 12:55PM	Why STAAR Surgical (STAA) Stock Is Trading Lower Today (StockStory)
07:00AM	STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs (Business Wire)
Jan-30-26 01:00PM	Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems (Benzinga)
Jan-25-26 08:18PM	Analysts Question STAAR Surgical Company (STAA)'s Post-Merger Standalone Valuation (Insider Monkey)
Jan-23-26 04:35PM	Staar Surgical, Dynatrace, and More Stocks See Action From Activist Investors (Barrons.com)
Jan-16-26 08:39PM	Staar Surgical, Alumis, and More Stocks See Action From Activist Investors (Barrons.com)
09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
08:02AM	Here Are Fridays Top Wall Street Analyst Research Calls: ConocoPhillips, Devon Energy, Garmin, Honeywell, HP, PepsiCo, Rocket Labs, Seagate, and More (24/7 Wall St.)
05:00AM	Loading…
05:00AM	STAAR CEO exits after company rejects Alcon buyout (MedTech Dive)
Jan-15-26 11:04PM	STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
01:06PM	STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence (Benzinga)
08:30AM	STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement (Business Wire)
Jan-13-26 08:45AM	Mitsui Sumitomo Continues to Build WR Berkley Stake (24/7 Wall St.)
Jan-07-26 07:38AM	STAAR Surgical terminates Alcon merger agreement (Medical Device Network)
Jan-06-26 08:00PM	Alcon Terminates Agreement to Acquire STAAR Surgical (Business Wire) -6.91%
12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:14PM	Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30% (Investing.com)
09:52AM	Broadwood Partners Comments on STAAR Surgical Shareholders Rejection of the Companys Proposed Sale to Alcon (Business Wire)
08:47AM	STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders (Business Wire)
06:13AM	STAAR shareholders reject Alcons revised buyout offer (MedTech Dive)
Dec-19-25 03:51PM	Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for (Investing.com)
12:59PM	Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon (Business Wire)
11:45AM	Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders (Business Wire)
06:47PM	Loading…
Dec-17-25 06:47PM	Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day (Investing.com) -7.22%
04:53PM	Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. (PR Newswire)
01:17PM	Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails (Business Wire)
10:55AM	STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value (Business Wire)
Dec-16-25 03:58PM	ISS recommends STAAR Surgical deal, but warns shareholders have reason to object (Investing.com) +5.26%
01:32PM	Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory (Business Wire)
09:12AM	Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction (Business Wire)
07:00AM	Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon (Business Wire)
Dec-15-25 06:35PM	Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote "FOR" Alcon Merger (Business Wire)
Dec-12-25 05:29PM	Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against (Investing.com)
08:40AM	Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation "AGAINST" STAAR Surgical Sale to Alcon (Business Wire)
Dec-11-25 08:06PM	STAAR Surgical accuses activist Broadwood of misinformation campaign (Investing.com)
11:41AM	Why STAAR Surgical (STAA) Stock Is Up Today (StockStory)
09:47AM	STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process (Business Wire)
07:00AM	Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon (Business Wire)
Dec-10-25 01:34PM	STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon (Investing.com) -5.50%
07:05AM	Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer (Business Wire)
Dec-09-25 02:25PM	Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against (Investing.com) +7.84%
02:16PM	STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know (StockStory)
12:39PM	Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical (Business Wire)
12:00PM	What Makes Staar Surgical (STAA) a New Buy Stock (Zacks)
08:30AM	Alcon Announces Amended Merger Agreement with STAAR Surgical (Business Wire)
Dec-08-25 04:11PM	Why STAAR Surgical (STAA) Shares Are Plunging Today (StockStory) -7.25%
01:28PM	Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process (Business Wire)
08:16AM	Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
08:00AM	STAAR Surgical Announces Expiration of Go-Shop Period (Business Wire)
Dec-04-25 10:35PM	STAAR Surgical (NASDAQ:STAA) Q3 Earnings: Leading The Medical Devices & Supplies - Specialty Pack (StockStory)
Dec-03-25 12:02PM	Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears (Investing.com)
Dec-02-25 04:14PM	Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors (Business Wire)
Nov-26-25 03:34PM	Staar Surgical, Gold Royalty See Activist Action (Barrons.com)
Nov-18-25 04:15PM	STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote (Investing.com)
Nov-12-25 02:35PM	Exclusive: Broadwood says Alcons earnings reveal STAAR bid came from weakness (Investing.com) -5.66%
Nov-10-25 06:38PM	Broadwood continues pressure on STAAR board, urges new directors amid go-shop move (Investing.com)
01:00PM	STAARs largest shareholder requests new directors in ongoing Alcon merger dispute (Medical Device Network)
08:00AM	Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process (Business Wire)
Nov-07-25 04:22PM	STAAR Surgical opens go-shop window amid shareholder revolt over Alcon deal (Investing.com)
10:10AM	STAAR Surgical Announces Amendments to Alcon Merger Agreement (Business Wire)
Nov-06-25 06:21AM	Yunqi Capital Applauds STAAR Surgicals Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated (Business Wire) +5.47%
Nov-05-25 04:27PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2025 Results (Business Wire)
Nov-04-25 11:32PM	3 Stocks Under $50 We Keep Off Our Radar (StockStory)
03:13PM	Alcon, Broadwood trade blows in fight for STAAR Surgicals future (Investing.com)
11:52AM	Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects (Business Wire)
01:00AM	Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders (Business Wire)
Oct-31-25 12:00PM	Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon (Business Wire)
11:14AM	Alcon rejects raised bid for STAAR Surgical as shareholders revolt (Investing.com)
Oct-27-25 04:43PM	Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass. (Barrons.com) +5.75%
08:00AM	STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon (Business Wire)
Oct-24-25 06:03PM	Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon (Business Wire)
01:59PM	Exclusive: Roughly 72% of STAAR Surgical shares oppose Alcon deal, vote delayed (Investing.com)
08:00AM	Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction (Business Wire)
Oct-23-25 12:09PM	Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders (Business Wire) +8.27%
Oct-22-25 02:35PM	Broadwood moves to oust STAAR Surgical directors over Alcon deal (Investing.com) -6.71%
06:17AM	Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors (Business Wire)
Oct-20-25 05:32PM	Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction (Business Wire) +5.41%
08:42AM	Broadwood Partners Highlights Growing Opposition to STAAR Surgicals Proposed Sale to Alcon (Business Wire)
07:30AM	STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025 (Business Wire)
Oct-17-25 08:00AM	Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale (Business Wire)
Oct-16-25 06:54PM	ISS recommendation may toll the bell for STAARAlcon deal, validates Broadwood (Investing.com) -5.97%
04:15PM	STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon (Business Wire)
Oct-15-25 01:36PM	Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
Oct-14-25 02:29PM	Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon (Business Wire)
Oct-12-25 08:02PM	Broadwood slams STAAR board over carelessness in Alcon sale defense (Investing.com)
Oct-10-25 01:11PM	Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale (Business Wire)
Oct-09-25 09:28AM	Glass Lewis recommends against STAARAlcon merger, bolstering Broadwoods campaign (Investing.com)
Oct-08-25 11:40AM	STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WHITE Proxy Card (Business Wire)
11:16AM	Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote AGAINST Sale to Alcon (Business Wire)
08:00AM	Broadwood Partners Questions Integrity of STAAR Surgical's Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon (Business Wire)
Oct-07-25 11:25AM	Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon (PR Newswire)
Oct-06-25 04:01PM	Yunqi Capital, One of STAAR Surgical Company's Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon (Business Wire)

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jiang Wei	Director	Jan 12 '26	Option Exercise	0.00	20,967	0	66,444	Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 09 '26	Buy	22.05	27,485	606,138	15,453,629	Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 06 '26	Buy	21.62	336,946	7,284,281	15,356,437	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 07 '26	Buy	22.00	66,467	1,462,301	15,422,904	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 08 '26	Buy	21.94	3,240	71,082	15,426,144	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 21 '25	Buy	27.86	797,486	22,218,837	15,019,491	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 20 '25	Buy	27.14	393,382	10,675,325	14,222,005	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 19 '25	Buy	26.42	309,132	8,166,155	13,828,623	Nov 21 09:55 PM
Jiang Wei	Director	Nov 12 '25	Option Exercise	0.00	20,967	0	45,477	Nov 14 06:00 PM
Jiang Wei	Director	Aug 12 '25	Option Exercise	0.00	20,967	0	24,510	Aug 13 06:39 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	1,750	47,025		Aug 05 06:38 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	13,491	362,523		Aug 05 06:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 08 '25	Buy	15.32	178,127	2,729,095	13,510,391	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 09 '25	Buy	15.08	8,200	123,676	13,518,591	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 10 '25	Buy	15.18	900	13,658	13,519,491	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 04 '25	Buy	15.91	497,631	7,917,191	13,194,210	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 03 '25	Buy	16.97	209,535	3,555,138	12,696,579	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 07 '25	Buy	15.61	138,054	2,155,174	13,332,264	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 02 '25	Buy	17.43	31,780	553,925	12,487,044	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 31 '25	Buy	17.46	22,189	387,360	12,455,264	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 26 '25	Buy	17.50	101,633	1,778,517	12,421,324	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 28 '25	Buy	17.47	8,131	142,014	12,433,075	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 27 '25	Buy	17.48	3,620	63,294	12,424,944	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 21 '25	Buy	17.74	102,400	1,816,545	12,285,395	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 25 '25	Buy	17.44	34,296	598,177	12,319,691	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 20 '25	Buy	17.96	108,720	1,952,992	12,182,995	Mar 20 07:51 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 18 '25	Buy	17.54	93,124	1,633,291	12,074,275	Mar 20 07:51 PM
Foust Warren	Chief Operating Officer	Mar 12 '25	Option Exercise	0.00	8,175	0	26,088	Mar 14 07:24 PM
Michna Magda	Chief Clinical, Regulatory,	Mar 12 '25	Option Exercise	0.00	6,177	0	18,554	Mar 14 07:21 PM
SISITSKY NATHANIEL	General Counsel	Mar 12 '25	Option Exercise	0.00	5,827	0	27,762	Mar 14 07:20 PM
Williams Patrick F.	Chief Financial Officer	Mar 12 '25	Option Exercise	0.00	8,153	0	56,242	Mar 14 07:19 PM
Williams Patrick F.	Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	4,061	0	48,089	Mar 11 08:40 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '25	Option Exercise	0.00	5,689	0	44,028	Mar 11 08:40 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 04 '25	Buy	17.24	27,953	481,849	11,981,151	Mar 06 07:07 PM
FARRELL STEPHEN C	President & CEO	Mar 05 '25	Option Exercise	6.95	20,000	138,900	35,156	Mar 06 05:47 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 27 '25	Buy	17.05	259,316	4,420,106	11,548,753	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 03 '25	Buy	16.64	249,503	4,151,214	11,953,198	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 28 '25	Buy	17.45	154,942	2,704,235	11,703,695	Mar 03 07:12 PM

BSX

Boston Scientific Corp

STAA

Staar Surgical Co

Upgrade your FINVIZ experience